We are live on ! Find out more
CAPR icon

Capricor Therapeutics
CAPR

19 hedge funds and large institutions have $3.01M invested in Capricor Therapeutics in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

377% more capital invested

Capital invested by funds: $630K → $3.01M (+$2.38M)

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

6% more funds holding

Funds holding: 18 → 19 (+1)

0.09% more ownership

Funds ownership: 0.34% → 0.42% (+0.09%)

Holders
19
Holders Change
+1
Holders Change %
+5.56%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
3
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$429K
2
Jane Street
Jane Street
New York
+$75.2K
3
Wells Fargo
Wells Fargo
California
+$42.3K
4
TSS
Two Sigma Securities
New York
+$30.6K
5
CFN
Cordasco Financial Network
Florida
+$3.71K

Top Sellers

1
CBA
Coastal Bridge Advisors
Connecticut
-$77.8K
2
Goldman Sachs
Goldman Sachs
New York
-$34K
3
Morgan Stanley
Morgan Stanley
New York
-$20K
4
SM
Sabby Management
Florida
-$20K
5
SEI Investments
SEI Investments
Pennsylvania
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.34M +$429K +35,852 +428%
CBA
2
Coastal Bridge Advisors
Connecticut
$362K -$77.8K -6,500 -35%
BAM
3
Belpointe Asset Management
Nevada
$249K +$98.4K +8,224 New
Jane Street
4
Jane Street
New York
$190K +$75.2K +6,286 New
Geode Capital Management
5
Geode Capital Management
Massachusetts
$160K – – –
AA
6
Apriem Advisors
California
$152K – – –
FWM
7
Frontier Wealth Management
Missouri
$142K – – –
Wells Fargo
8
Wells Fargo
California
$107K +$42.3K +3,530 New
GPCM
9
Granite Point Capital Management
Massachusetts
$102K – – –
TSS
10
Two Sigma Securities
New York
$78K +$30.6K +2,559 New
Northern Trust
11
Northern Trust
Illinois
$52K – – –
HIIFS
12
Harel Insurance Investments & Financial Services
Israel
$21K – – –
BlackRock
13
BlackRock
New York
$16K +$479 +40 +8%
Bank of America
14
Bank of America
North Carolina
$12K +$1.2K +100 +33%
CFN
15
Cordasco Financial Network
Florida
$9K +$3.71K +310 New
FANJ
16
Financial Architects (New Jersey)
New Jersey
$6K – – –
JP Morgan Chase
17
JP Morgan Chase
New York
$4K – – –
Deutsche Bank
18
Deutsche Bank
Germany
$3K +$1.44K +120 New
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
$1K – – –
Goldman Sachs
20
Goldman Sachs
New York
– -$34K -4,082 Closed
SM
21
Sabby Management
Florida
– -$20K -2,420 Closed
Morgan Stanley
22
Morgan Stanley
New York
– -$20K -2,400 Closed
SEI Investments
23
SEI Investments
Pennsylvania
– -$1K -100 Closed

CAPR Hedge Fund Activity: Q3 2017 in Review

19 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Capricor Therapeutics (CAPR) for Q3 2017, worth a combined $3.01M — up 377% from $630K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new CAPR positions and 4 closed out — a net gain of 2 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was Vanguard Group, adding an estimated $429K. The largest seller was Coastal Bridge Advisors, cutting an estimated $77.8K.

  • 19 institutional investors held Capricor Therapeutics (CAPR) as of Q3 2017, up from 18 in Q2 2017.
  • Funds reported $3.01M of Capricor Therapeutics stock for Q3 2017, up 377% quarter-over-quarter.
  • 6 funds opened new Capricor Therapeutics positions in Q3 2017 and 4 closed out, a net change of +2 holders.
  • The largest Capricor Therapeutics buyer in Q3 2017 was Vanguard Group, an estimated $429K added.
  • The largest Capricor Therapeutics seller in Q3 2017 was Coastal Bridge Advisors, an estimated $77.8K sold.

Based on aggregated 13F filings for Q3 2017.